VR Logo

Lupin Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Deshbandhu Gupta

Group: Lupin

Listing: NSE: LUPIN, BSE: 500257

Headquarters: Mumbai, Maharashtra

Website: www.lupinworld.com

Key Facts

Market cap: R 39,407.16 Cr

Revenue (TTM): R 16,953.62 Cr

Earnings (TTM): R -369.14 Cr

Cash: R 3,097.06 Cr

Total Debt: R 8,496.15 Cr

Promoters' ownership: 46.92%

Liquidity: High

52 Week range: R 504.75 - 919.20

Face value: R2.00

Shares outstanding: 45,30,60,010

10 Years Aggregate:

  • CFO: 15,170.65 Cr
  • EBITDA: 26,706.93 Cr
  • Net Profit: 13,808.48 Cr

Stock Performance

Time Period Lupin S&P BSE Sensex S&P BSE Healthcare
YTD13.71-21.4016.51
1 month1.82-3.842.05
3 months35.97-15.3416.07
1 Year18.57-18.3617.60
3 Years-7.781.354.88
5 Years-13.833.10-1.53
10 Years9.076.7011.04
As on 29-May-2020
Year Lupin S&P BSE Sensex S&P BSE Healthcare
2019-9.2714.38-3.55
2018-4.595.87-5.89
2017-40.4827.910.49
2016-19.421.95-12.88
201528.55-5.0315.06
201455.8029.8947.43
201347.748.9822.55